This retrospective study evaluated using nonstapling bullectomy via manual suturing as an alternative to traditional staple bullectomy in reducing the recurrence rate of primary spontaneous pneumothorax (PSP) in young male patients. The authors utilized hybrid VATS (hVATS) with a one-port-one-window approach for manual suturing.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Lung
November 14, 2024
November 7, 2024
Recently, the CALGB 140503 trial and the JCOG0802/WJOG4607L showed the non-inferiority of sublobar resections compared to lobectomy for <2cm non-small cell lung cancer.
November 7, 2024
This article explores the disparities in access to minimally invasive surgery (MIS) for stage I non-small cell lung cancer (NSCLC) based on socioeconomic status.
November 6, 2024
CTSNet Editor-in-Chief Joel Dunning spoke with Shaf Keshavjee about his keynote speech at ESTS.
November 4, 2024
CTSNet Editor-in-Chief Joel Dunning spoke with Hiran C. Fernando about the JoLT-CA/STABLEMATES trial.
November 4, 2024
This video demonstrates a bi-portal VATS lower lobectomy that has been performed using the ArtiSential Bipolar Precise Dissector.
October 31, 2024
The authors developed a cost-effective, high-fidelity simulation for VATS wedge resection training using an ex-vivo porcine lung with simulated lung nodules in the form of cherry tomatoes affixed with cyanoacrylate glue that is assessed with an Objective Structured Assessment of Technical Skills (OSATS) tool.
October 31, 2024
The role of transcatheter aortic valve replacement (TAVR) for the treatment of aortic stenosis in the pre- and post-lung transplant population is limited. This specific patient population is considered high risk for general anesthesia and for surgical aortic valve replacement.
October 24, 2024
This article evaluates the effectiveness of neoadjuvant immunotherapy combined with chemotherapy (IC+Chemo) in treating non-small cell lung cancer (NSCLC). This large-scale study involved 1,092 patients from 11 medical centers and compared outcomes between those who received IC+Chemo and those who received chemotherapy alone.
October 24, 2024
This retrospective study compared outcomes for 90-day mortality and five-year overall survival estimates in patients who underwent lobectomy, segmentectomy, or wedge resection for stage c-IA lung carcinoma between 2016-2022.